Kratom attracts investor attention after regulatory win
Looks like the recent decision by the World Health Organization to decline a “critical revue” of Kratom is spurring pharmaceutical interest in our favorite plant.
-
Big Pharma and Kratom
-
Looks like the first link didn’t work.
-
@pete2000 Thanks for the link. 👍 Big pharma always takes plants apart to the molecular level, and twist it into something stronger/evil. (poppy sap, cannabis flower, coca leaves, and now kratom and mushrooms!)
follow the money, its leads to patents on plants and to big phama.
-
oh man - gotta clear the path right.
Also hey guys happy new year.
